Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
23.99
-0.31 (-1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 56.02 | 31.4 | 28.2 | 28.72 | 13.45 | 2.79 | |
Research & Development | 258.45 | 210.76 | 142.76 | 121.31 | 45.2 | 11.04 | |
Operating Expenses | 314.47 | 242.16 | 170.96 | 150.03 | 58.65 | 13.83 | |
Operating Income | -314.47 | -242.16 | -170.96 | -150.03 | -58.65 | -13.83 | |
Interest Expense | - | - | - | - | -0.4 | - | |
Interest & Investment Income | 21.08 | 7.64 | 2.92 | 0.74 | 0.06 | 0.29 | |
Currency Exchange Gain (Loss) | -1.16 | -1.39 | -0.02 | - | - | - | |
Other Non Operating Income (Expenses) | - | - | - | - | -0.45 | - | |
EBT Excluding Unusual Items | -294.54 | -235.91 | -168.07 | -149.28 | -59.44 | -13.54 | |
Gain (Loss) on Sale of Investments | 0.03 | -0.02 | -0.03 | -0.01 | - | - | |
Other Unusual Items | - | - | - | - | - | -1.32 | |
Pretax Income | -294.51 | -235.94 | -168.1 | -149.29 | -59.44 | -14.86 | |
Net Income | -294.51 | -235.94 | -168.1 | -149.29 | -59.44 | -14.86 | |
Net Income to Common | -294.51 | -235.94 | -168.1 | -149.29 | -59.44 | -14.86 | |
Shares Outstanding (Basic) | 84 | 60 | 52 | 51 | 14 | 2 | |
Shares Outstanding (Diluted) | 84 | 60 | 52 | 51 | 14 | 2 | |
Shares Change (YoY) | 45.97% | 14.83% | 2.12% | 253.54% | 489.30% | 415.39% | |
EPS (Basic) | -3.51 | -3.95 | -3.23 | -2.93 | -4.13 | -6.08 | |
EPS (Diluted) | -3.51 | -3.95 | -3.23 | -2.93 | -4.13 | -6.08 | |
Free Cash Flow | -244.42 | -188.89 | -156.71 | -123.18 | -47.67 | -13.48 | |
Free Cash Flow Per Share | -2.91 | -3.16 | -3.02 | -2.42 | -3.31 | -5.52 | |
EBITDA | -312.84 | -240.49 | -169.28 | -148.94 | -57.95 | -13.56 | |
D&A For EBITDA | 1.62 | 1.67 | 1.68 | 1.09 | 0.7 | 0.27 | |
EBIT | -314.47 | -242.16 | -170.96 | -150.03 | -58.65 | -13.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.